SavedAdd your journal

Journals / Retina-Vitreus / 2015 / Cilt: 23 - Sayı: 3

Nonarteritic Anterior Ischemic Optic Neuropathy Treatments and Current Innovations

Non-Arteritik Anterior İskemik Optik Nöropati Tedavisi ve Güncel Yenilikler

ÖMER KARTI
EYYÜP KARAHAN
Murat UYAR
Tuncay KÜSBECİ
Pages
265–274
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The aim of this review is to discuss the traditional treatment methods and current innovations in the nonarteritic ischemic optic neuropathy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Nonarteritic anterior ischaemic optic neuropathy (NAION) is the most common acute opticneuropathy in people older than 50 years.
📊
Key Findings & Data:The clinic condition is caused by infarction of the laminar or retrolaminar portion of the optic nerve head supplied by the short posterior ciliary arteries.
💡
Conclusion & Impact:The aim of this review is to discuss the traditional treatment methods and current innovations in the nonarteritic ischemic optic neuropathy.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Nonarteritic anterior ischaemic optic neuropathy (NAION) is the most common acute opticneuropathy in people older than 50 years. The clinic condition is caused by infarction of the laminar or retrolaminar portion of the optic nerve head supplied by the short posterior ciliary arteries. The underlying aetiology and pathophysiology is poorly elucidated.Most treatments proposed for NAION are empirical and include a wide spectrum of agents presumed to effect on thrombosis, on the blood vessels, on the disc edema, or on the neuroprotection. Currently, there is no proven effective long-term treatment for this disorder. The aim of this review is to discuss the traditional treatment methods and current innovations in the nonarteritic ischemic optic neuropathy.

Özet

Nonarteritik anterior iskemik optik nöropati (NAİON) 50 yaş üstünde en sık görülen optik nöropatidir. Optik sinirin kısa posterior siliyer arterlerle beslenen laminer veya retrolaminer kısmının enfarktının neden olduğu klinik durumdur. Altta yatan etiyoloji ve patofizyoloji yetersiz aydınlatılmıştır. NAİON için önerilen tedavilerin hepsi deneyseldir, tromboz, kan damarları, disk ödemi veya nöroproteksiyon üzerine etkili olduğu düşünülen geniş spektrumda ajanlar içerir. Günümüzde bu hastalık için uzun vadede kanıtlanmış etkili bir tedavi yoktur. Bu çalışmanın amacı nonarteritik iskemik optik nöropa-tide geleneksel tedavi yöntemlerini ve güncel yenilikleri tartışmaktır

🔖

Cite This Article

KARTI, Ö., KARAHAN, E., UYAR, M., KÜSBECİ, T. (2015). Nonarteritic Anterior Ischemic Optic Neuropathy Treatments and Current Innovations. Retina-Vitreus, Cilt: 23 - Sayı: 3, 265–274. https://ajindex.com/articles/307647

References (12)

  1. Kelman SE, Iskemic optik neuropathies. In: Miller NR, Newman NJ, eds. Walsh&Hoyt's Clinical Neuro-Opthalmology Vol.1.2nd ed. Baltim ore:Williams&Wilkins:1997:549-98.
  2. Johnson LN, Arnold AC. Incidence of nonarteritic and arteritic ante- rior ischemic optic neuropathy. Population-based study in the state of Missouri and Los Angeles County, California. J Neuroophthalmol 1994;14:38-44.
  3. Hattenhauer MG, Leavitt JA, Hodge DO. et al. Incidence of nonarteritic anterior ischemic optic neuropathy.Am J Ophthalmol 1997;123:103-7.
  4. Hayreh SS, Joos KM, Podhajsky PA, et al. Systemic diseases associa- ted with nonarteritic anterior ischemic optic neuropathy. Am J Opthal- mol 1994;118:766-80.
  5. Boghen DR, Glaser JS. Ischaemic optic neuropathy. The clinical profile and history. Brain 1975;98:689-708. Ischemic Optic Neuropathy Decompression Trial Research Group. Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial. Arch Ophthalmol 1996;114:1366-74.
  6. Talks SJ, Chong NH, Gibson JM et al. Fibrinogen, cholesterol and smoking as risk factors for non-arteritic anterior ischaemic optic neu- ropathy. Eye 1995;9:85-8.
  7. Acheson JF, Sanders MD. Coagulation abnormalities in ischemic optic neuropathy. Eye 1994;8:88-92.
  8. Hayreh SS, Zimmerman MB, Podhajsky P. et al. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disor- ders.Am J Ophthalmol 1994:15;117:603-24.
  9. Taylor D, Ramsay J, Day S, Dillon M. Infarction of the optic nerve head in children with accelerated hypertension.Br J Ophthalmol 1981;65:153-60. Hayreh SS. Blood flow in the optic nerve head and factors that may influence it. Progress in Retinal and Eye Research 2001;20:595-624. Burde RM. Optic disk risk factors for nonarteritic anterior ischemic optic neuropathy.Am J Ophthalmol 1993:15;116:759-64.
  10. Beck RW, Savino PJ, Repka MX. et al. Optic disc structure in anterior ischemic optic neuropathy. Ophthalmology 1984;91:1334-7. Hayreh SS. Factors influencing blood flow in the optic nerve head. J. Glaucoma 1997;6:412-25. Valerie Purvin. Ischemic optic neuropathy. Seminars in Cerebrovascu- lar Diseases and Stroke 2004;4:18-38.
  11. Mojon DS, Hedges TR,Ehrenberg B, et al. Association between sleep apnea syndrome and nonarteritic anterior ischemic optic neuropathy. Arch Ophthalmol 2002;120:601-5.
  12. Galvez-Ruiz A, Arishi N. Sequential, non-arteritic anterior ischemic optic neuropathy in patients taking sildenafil: a report of ten ca